Rocket One (RKTO) Other Non Operating Income (2019 - 2026)
Rocket One's (RKTO) quarterly Other Non Operating Income came in at $149.0 in Q1 2026, down 17.68% year-over-year from $181.0 in Q1 2025, and down 5.7% quarter-over-quarter from $158.0 in Q4 2025.
Analysis
Rocket One (RKTO) Other Non Operating Income (2019 - 2026) Analysis & Trends
Rocket One has disclosed Other Non Operating Income across 8 years of filings, most recently posting $149.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 17.68% year-over-year to $149.0; the TTM figure through Mar 2026 stood at $648.0 (down 95.35% YoY), while the FY2025 annual figure was $680.0, down 97.55% from the prior year.
- Other Non Operating Income came in at $149.0 for Q1 2026 at Rocket One, down from $158.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $410309.0 in Q4 2022 to a low of -$188420.0 in Q4 2023.
- Average Other Non Operating Income over 5 years is $18651.3, with a median of $186.5 recorded in 2024.
- The largest YoY upside for Other Non Operating Income was 1047.8% in 2023 against a maximum downside of 145.92% in 2023.
- Over 5 years, Other Non Operating Income stood at $410309.0 in 2022, then tumbled by 145.92% to -$188420.0 in 2023, then soared by 100.1% to $192.0 in 2024, then slipped by 17.71% to $158.0 in 2025, then slipped by 5.7% to $149.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $149.0 in Q1 2026, $158.0 in Q4 2025, and $168.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn |
| 10 | Rocket One | 13.80 Mn | 5.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 149.00 |
| Dec 31, 2025 | 158.00 |
| Sep 30, 2025 | 168.00 |
| Jun 30, 2025 | 173.00 |
| Mar 31, 2025 | 181.00 |
| Dec 31, 2024 | 192.00 |
| Sep 30, 2024 | 200.00 |
| Jun 30, 2024 | 13,365.00 |
| Mar 31, 2024 | 13,956.00 |
| Dec 31, 2023 | -188,420.00 |
| Sep 30, 2023 | 5,611.00 |
| Jun 30, 2023 | 1,548.00 |
| Dec 31, 2022 | 410,309.00 |
| Sep 30, 2022 | -592.00 |
| Jun 30, 2022 | -262.00 |
| Mar 31, 2022 | 41,685.00 |
| Dec 31, 2021 | -116,346.00 |
| Sep 30, 2021 | -29,135.00 |
| Jun 30, 2021 | -29,479.00 |
| Mar 31, 2021 | -17,930.00 |